Kaili Hu
Shanghai University
16 Papers
38 Citations
Kaili Hu is an academic researcher from Shanghai University. The author has contributed to research in topics: Bioavailability & Drug carrier. The author has an hindex of 7, co-authored 16 publications.
Chat about Author
Papers
Enhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluation
TL;DR: The results indicate that DTX-LNs were valuable as an oral drug delivery system to enhance the absorption of docetaxel.
The construction of puerarin nanocrystals and its pharmacokinetic and in vivo-in vitro correlation (IVIVC) studies on beagle dog.
TL;DR: It is concluded that nanocrystal technique is an efficient technology to improve the oral bioavailability of puerarin and in vivo-in vitro correlation was established in this study.
36
Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat
TL;DR: It is concluded that nanocrystal technique is an efficient technology to improve the oral bioavailability of puerarin by observing an increasing of Cmax and AUC and a decreasing of CL/F with the decreasing of particle size.
35
Nose-to-brain delivery of borneol modified tanshinone IIA nanoparticles in prevention of cerebral ischemia/reperfusion injury
Luting Wang,Luting Wang,Lin Xu,Junfeng Du,Xiao Zhao,Mei Liu,Jianfang Feng,Jianfang Feng,Kaili Hu +8 more
TL;DR: In this paper, the authors developed Bo-TSA-NP, a novel tanshinone IIA (TSA) loaded nanoparticles modified by borneol, which has long been proved with the ability to enhance other drugs' transport across the BBB.
26
Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles.
TL;DR: In this article, a novel RGD-modified PEGylated lipid-core micelle delivery system was designed to improve the anti-cancer effect of docetaxel on triple negative breast cancer (TNBC).
24